Stay updated on Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Sign up to get notified when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    A new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.
    Difference
    0.1%
    Check dated 2026-04-16T18:36:36.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision history updated: added v3.5.0 and removed v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-18T22:18:52.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    A new history entry Revision: v3.4.3 was added and Revision: v3.4.2 was removed from the study record history.
    Difference
    0.1%
    Check dated 2026-03-11T17:57:07.000Z thumbnail image
  6. Check
    68 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed a general funding/status notice; these are minor maintenance updates to the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.7%
    Check dated 2026-02-11T02:17:01.000Z thumbnail image
  7. Check
    75 days ago
    Change Detected
    Summary
    Added a government-funding-status notice and a new system revision tag (Revision: v3.4.1); the prior revision tag (Revision: v3.4.0) was removed.
    Difference
    0.7%
    Check dated 2026-02-04T00:40:20.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    The history page now includes a glossary toggle and color-coded highlights for additions and deletions (green and red). The latest revision is shown as v3.4.0, replacing the previous v3.3.4.
    Difference
    0.8%
    Check dated 2026-01-28T00:27:12.000Z thumbnail image

Stay in the know with updates to Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vedolizumab for aGVHD Prophylaxis in Allo-HSCT Clinical Trial page.